Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Daily News

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

Caitlin E. Cox

August 16, 2024

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News

Type A Aortic Dissection Tied to Greater Mortality in Women

Yael L. Maxwell

June 11, 2021

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Daily News

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Yael L. Maxwell

April 03, 2015

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Daily News

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Yael L. Maxwell

March 09, 2013

Advertisement

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

September 2022 News Roundup

Type A Aortic Dissection Tied to Greater Mortality in Women

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content